Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Potassium Channel Tetramerisation Domain Containing 17 (KCTD17) (Middle Region) Peptide

KCTD17 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN5672785

Quick Overview for Potassium Channel Tetramerisation Domain Containing 17 (KCTD17) (Middle Region) Peptide (ABIN5672785)

Target

KCTD17 (Potassium Channel Tetramerisation Domain Containing 17 (KCTD17))

Origin

Human

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequence

    DQAEFLCVVS KELHSTPNGL SSESSRKTKS TEEQLEEQQQ QEEEVEEVEV

    Characteristics

    This is a synthetic peptide designed for use in combination with anti- KCTD17 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    KCTD17 (Potassium Channel Tetramerisation Domain Containing 17 (KCTD17))

    Background

    Is a positive regulator of ciliogenesis, playing a crucial role in the initial steps of axoneme extension. It acts as a substrate-adapter for CUL3-RING ubiquitin ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of TCHP, a protein involved in ciliogenesis down-regulation. May be involved in endoplasmic reticulum calcium ion homeostasis.

    Protein Size: 321

    Gene ID

    79734

    NCBI Accession

    NM_001282684, NP_001269613

    UniProt

    Q8N5Z5
You are here:
Chat with us!